Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Horm Res Paediatr ; 2023 Nov 10.
Article in English | MEDLINE | ID: mdl-37952514

ABSTRACT

INTRODUCTION: The optimal dietary strategy to improve the metabolic and reproductive endocrine profile in adolescents with obesity and polycystic ovary syndrome is undefined. This study was conducted to evaluate the efficacy of the MEtabolic Syndrome REduction in NAvarra (RESMENA) diet versus a control diet based on American Heart Association (AHA) recommendations for the treatment of PCOS in adolescents with PCOS. METHODS: A total of 40 adolescents diagnosed with PCOS between the ages of 13-18 years were randomized to either a RESMENA or control diet for 6 months. Dietary status, anthropometry, body composition, biochemical parameters, and reproductive endocrine hormones were compared between the 2 groups before and after the intervention. RESULTS: Both diet groups showed significant decreases in anthropometric parameters whereas the RESMENA diet provided a greater decrease in all these parameters except neck circumference and fat percentage (p<0.05). At the end of the study fasting insulin, ALT, and total cholesterol levels decreased in both control and RESMENA group, HbA1c, HOMA-IR, and hsCRP levels decreased and QUICKI score increased in the RESMENA group (p<0.05). There was no statistical difference in the androgen levels of the control group compared to the baseline. In the RESMENA group, there was a significant decrease in total testosterone, free testosterone, 17-OH progesterone, androstenedione, LH levels and LH/FSH ratio and free androgen index and a significant increase in SHGB levels (p<0.05). CONCLUSIONS: Both dietary patterns resulted in significant improvement in anthropometric measurements and body composition, but the RESMENA diet showed beneficial effects on insulin resistance parameters and androgen levels.

2.
Front Endocrinol (Lausanne) ; 14: 1190445, 2023.
Article in English | MEDLINE | ID: mdl-37409230

ABSTRACT

Purpose: Our study aimed to examine the effects of blue light exposure on prepubertal male rats' puberty and testis tissue. Methods: Eighteen 21-day-old male Sprague Dawley rats were divided into three groups consisting of six rats in each group: Control Group (CG), Blue Light-6 hours (BL-6), and Blue Light-12 hours (BL-12). CG rats were maintained with 12/12-hour light-dark cycles. The rats of BL-6 and BL-12 were exposed to blue light (450-470nm/irradiance level 0.03uW/cm2) for 6 hours and 12 hours, respectively. Rats were exposed to blue light until the first signs of puberty. The ELISA method was used to analyze the serum levels of FSH, LH, testosterone, DHEA-S, leptin, ghrelin, melatonin, glutathione, glutathione peroxidase, and malondialdehyde. Testes were dissected for histomorphological examination. Results: The medians of the pubertal entry days of the CG, BL-6, and BL-12 were 38th, 30th, and 28th days, respectively. (p:0.001) The FSH, LH, and testosterone concentrations of all groups were similar. The FSH concentration increased as the LH concentration increased (r: 0.82 p: 0.001). The serum LH concentration increased as serum testosterone, and DHEAS decreased, respectively (r: -0.561, p: 0.01) (r:-0.55 p:0.01). Testicular lengths and weights of the BL groups were smaller compared to CG (p: 0.03),(p: 0.04). GPx was higher for BL-6 and BL-12 than the CG (p:0.021, p:0.024). Testis tissue was compatible with the pubertal period in all groups. As the blue light exposure time increased, spermatogenesis was suppressed, and capillary dilatation and edema in the testis tissue increased. Conclusion: Our study is the first to show the effects of blue light exposure on male rats' puberty process. And we showed that exposure to blue light and the duration of exposure lead to precocious puberty in male rats. The blue light exposure suppressed spermatogenesis, marked vasodilatation in the interstitial area of the testis, and disrupted the integrity of the basement membrane. These findings intensified with increasing exposure time.


Subject(s)
Follicle Stimulating Hormone , Sexual Maturation , Rats , Male , Animals , Rats, Sprague-Dawley , Testis , Testosterone
3.
Am J Med Genet C Semin Med Genet ; 193(2): 193-197, 2023 06.
Article in English | MEDLINE | ID: mdl-37186482

ABSTRACT

Bone marrow failure type 3 (BMFS3) (MIM:617052) is a subtype of inherited bone marrow failure syndromes (IBMFS) caused by homozygous pathogenic variants in DNAJC21. It was first defined in 2016, and to date, 19 patients have been reported. Here we report the first adult patient; a 20-year-old female with a novel frameshift variant in DNAJC21 presents with thrombocytopenia, dysmorphic findings, and ovarian agenesis. Our patient expands the clinical spectrum to the milder end and suggests that DNAJC21-related disorders can have relatively mild presentations. Investigation of DNAJC21 variants in both childhood and adult patients with persistent, non-progressive thrombocytopenia will allow to broaden the gene-related phenotypic and genotypic spectrum and elucidate the pathophysiology. Therefore, we encourage revisiting undiagnosed patients to offer whole exome sequencing (WES) in adulthood.


Subject(s)
Thrombocytopenia , Humans , Female , Young Adult , Child , Adult , Genotype , Exome Sequencing , Thrombocytopenia/diagnosis , Thrombocytopenia/genetics , HSP40 Heat-Shock Proteins/genetics
4.
J Clin Res Pediatr Endocrinol ; 15(4): 365-374, 2023 11 22.
Article in English | MEDLINE | ID: mdl-37212628

ABSTRACT

Objective: This study was designed to examine the effect of blue light exposure and exposure time on puberty in an animal model. Methods: Eighteen 21-day-old female Sprague Dawley rats were divided into three equal groups which were: control group (CG); blue light-6 hours (BL-6); and blue light-12 hours (BL-12). CG rats were maintained with 12/12-hour light-dark cycles. The animals in BL-6 and BL-12 were exposed to blue light of wavelength 450-470 nm and intensity of 0.03 uW/cm2 for 6 and 12 hours, respectively. Exposure to blue light continued until the first signs of puberty. Serum follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol, testosterone, dehydroepiandrosterone sulfate (DHEA-S), leptin and melatonin were measured. Subsequently the ovaries and uterus were examined histomorphologically. Results: The median day of puberty start was 38, 32 and 30 for the CG, BL-6, and BL-12 groups, respectively (p=0.001). FSH, testosterone, DHEA-S, and leptin concentrations of all groups were similar. However, LH and estradiol concentrations in BL-6 were higher compared to CG (p=0.02). There was a negative correlation between blue light exposure, exposure time, and melatonin concentrations (r=-0.537, p=0.048). Ovarian tissue was compatible with puberty in all groups. As blue light exposure time increased, capillary dilatation and edema in the ovarian tissue increased. Prolonged exposure was associated with polycystic ovary-like (PCO) morphological changes and apoptosis in granulosa cells. Conclusion: These results suggest that exposure to blue light and the duration of exposure induced earlier puberty in female rats. As the duration of blue light exposure increased, PCO-like inflammation, and apoptosis were detected in the ovaries.


Subject(s)
Melatonin , Polycystic Ovary Syndrome , Rats , Female , Humans , Animals , Leptin , Rats, Sprague-Dawley , Luteinizing Hormone , Follicle Stimulating Hormone , Estradiol , Puberty , Testosterone , Dehydroepiandrosterone
5.
Turk J Med Sci ; 48(3): 531-536, 2018 Jun 14.
Article in English | MEDLINE | ID: mdl-29914248

ABSTRACT

Background/aim: Various studies have shown that adult patients with polycystic ovary syndrome (PCOS) have higher levels of anxiety and depression compared to their normal counterparts. However, it is still unclear whether these mood disorders already exist in adolescents affected by PCOS. The aim of the present study is to assess differences in anxiety and depression levels between adolescents with PCOS and age- and body mass index (BMI)-matched controls and to determine the possible factor(s) impacting these psychological parameters in adolescents with PCOS. Materials and methods: The study included 80 adolescents with PCOS and 50 age- and BMI-matched controls. All participants completed standardized questionnaires assessing anxiety and depression. A multiple linear regression model was used to analyze the impact of potential variables on anxiety and depression scores of the adolescents with PCOS. Results: Significantly higher levels of anxiety, specifically generalized and social anxieties, as well as depression were found in adolescents with PCOS compared to controls. Higher BMI was found to be associated with higher levels of depression and generalized anxiety, and higher modified Ferriman-Gallwey score with higher level of panic disorder in adolescents affected by PCOS. Conclusion: Adolescents with PCOS experience significantly more emotional distress compared to adolescents without PCOS. This emotional distress may be related, at least in part, to certain clinical features of PCOS including obesity and hirsutism. PCOS in adolescents should be assessed not only for the gynecological and metabolic aspects but also for the emotional aspects of the disease.

7.
J Clin Res Pediatr Endocrinol ; 8(3): 313-20, 2016 Sep 01.
Article in English | MEDLINE | ID: mdl-27097763

ABSTRACT

OBJECTIVE: Soluble endoglin (S-endoglin) has been implicated as a potential marker of endothelial dysfunction (ED) and was reported to be elevated in diabetic adults, correlating with the severity of diabetic vasculopathy. However, circulating S-endoglin and its association with other markers of ED have not been formerly analyzed in the first decade of diabetes onset in adolescents with type 1 diabetes mellitus (T1DM). METHODS: Fifty-eight adolescents with moderately/poorly controlled T1DM were included in this study and twenty-nine healthy adolescents served as controls. The diabetic group was divided into two groups based on the presence of microalbuminuria, as the microalbuminuria group (n=15) and the normoalbuminuria group (n=43). Functional vascular alterations were evaluated by measuring serum S-endoglin and plasma nitric oxide (NO) concentrations, the flow-mediated dilatation (FMD) of the brachial artery. Carotid intima media thickness (CIMT) was measured for evaluation of structural vascular alterations. RESULTS: The S-endoglin and NO levels of both microalbuminuria and normoalbuminuria groups were higher than those of the control group (for S-endoglin, p=0.047 and p<0.001; for NO, p=0.004 and p=0.006, respectively). The FMD percent was lower in the microalbuminuria group compared to the normoalbuminuria and control groups (p=0.036 and p=0.020, respectively). There were negative correlations between S-endoglin concentration and FMD percent (r=-0.213, p=0.051) and between serum S-endoglin concentration and albumin excretion rate (r=-0.361, p=0.005). No significant differences were found in CIMT among any of the groups (p=0.443). CONCLUSION: In adolescents with T1DM, S-endoglin concentrations might increase in parallel to the deterioration in endothelial function before subclinical structural vascular alterations become evident.


Subject(s)
Carotid Intima-Media Thickness , Diabetes Mellitus, Type 1/complications , Diabetic Angiopathies/blood , Endoglin/blood , Adolescent , Albuminuria/complications , Analysis of Variance , Biomarkers/blood , Blood Flow Velocity , Brachial Artery/pathology , Brachial Artery/physiopathology , Cross-Sectional Studies , Diabetic Angiopathies/diagnosis , Diabetic Angiopathies/etiology , Dilatation, Pathologic , Endothelium, Vascular/physiopathology , Female , Humans , Male , Nitric Oxide/blood , Solubility
8.
J Clin Res Pediatr Endocrinol ; 7(4): 336-9, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26777047

ABSTRACT

Individuals with 45,X/46,XY karyotype are at increased risk for germ cell tumor development. We report a case with a diagnosis of 45,X/46,XY gonadal dysgenesis who presented with short stature, physical stigmata of Turner syndrome. Her pubertal development was at Tanner stage 3. At follow-up, bilateral prophylactic gonadectomy was performed when considering the risk factors. Pathological assessment was consistent with gonadoblastoma in the left gonad, and dysgerminoma and gonadoblastoma in neighboring areas in the right gonad. The karyotype analysis of the right and left gonadal tissues reveled 45,X[97,3]/46,XY[2,7] and 45,X[92,7]/46,XY[4,5]/47,XYY [2,8] mosaic, respectively. The clinical management of such patient should be individualized according to the present risk factors. Additionally, signs of estrogenization like advanced breast development always suggest the possible presence of germ cell tumor.


Subject(s)
Dysgerminoma/diagnosis , Gonadal Dysgenesis, 46,XY/diagnosis , Mosaicism , Ovarian Neoplasms/diagnosis , Adolescent , Dysgerminoma/genetics , Dysgerminoma/surgery , Female , Gonadal Dysgenesis, 46,XY/genetics , Gonadal Dysgenesis, 46,XY/surgery , Gonadoblastoma/diagnosis , Gonadoblastoma/genetics , Gonadoblastoma/surgery , Humans , Karyotype , Ovarian Neoplasms/genetics , Ovarian Neoplasms/surgery , Phenotype , Turner Syndrome/diagnosis
9.
J Clin Res Pediatr Endocrinol ; 6(3): 174-6, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25241612

ABSTRACT

Arachnoid cysts (ACs), particularly suprasellar cysts, cause a wide spectrum of endocrine disorders. Herein, we report two patients diagnosed with an extensive AC in the middle cranial fossa while being investigated for etiologies of precocious puberty and short stature. One of them required surgery due to his pubertal disorders associated with compression effects of cyst. After surgery, his puberty progression was regressed within one year. On the other hand, surgery was not planned for the second patient considering of his cranial imaging findings and the extremely low incidence of growth hormone (GH) deficiency caused by middle fossa AC (MFAC). We started treatment with recombinant human GH and no complication was found during treatment follow-up. Endocrine disorders associated with MFACs are extremely rare. By presenting with these two cases, we aimed to remain our fellow physcians that ACs can be possibly cause of endocrine disorders. Clinicians should be careful evaluating endocrine disorders because real cause may not be cyst itself but masked by it.


Subject(s)
Arachnoid Cysts/diagnosis , Cranial Fossa, Middle , Arachnoid Cysts/complications , Arachnoid Cysts/therapy , Biomarkers/blood , Child , Cranial Fossa, Middle/drug effects , Cranial Fossa, Middle/pathology , Cranial Fossa, Middle/surgery , Decompression, Surgical , Growth Disorders/etiology , Hormone Replacement Therapy , Human Growth Hormone/blood , Human Growth Hormone/deficiency , Human Growth Hormone/therapeutic use , Humans , Infant , Magnetic Resonance Imaging , Male , Puberty, Precocious/etiology , Treatment Outcome
10.
Balkan Med J ; 29(4): 434-9, 2012 Dec.
Article in English | MEDLINE | ID: mdl-25207049

ABSTRACT

OBJECTIVE: To investigate the vaccination rate of influenza in diabetic children and the effect of recommendation and other factors on vaccination rate. MATERIAL AND METHODS: On July 2011, 144 diabetic children and their families were informed about and were recommended to receive the influenza vaccine every year, in September. On December 2011, parents were questioned about the vaccination. RESULTS: Influenza vaccination rate of the previous season (28.3%) increased to 50.0% (p<0.05). Receiving the vaccine in 2010 was the only contributing factor to the recommendation success. The reasons given by the non-receivers were; forgetting (50.0%), fear of adverse-effects (26.4%), not believing in usefulness (15.2%), rejection by the child (4.2%) and effects of media (4.2%). 88.9% of those who forgot declared that they would receive if they were reminded at the beginning of the season. CONCLUSION: The rate of influenza vaccination was low. The majority of those who didn't recieve the vaccination declared that they would if they were reminded at the beginning of the season and the fact that "receiving the vaccine in 2010" was the only factor influencing the recommendation success indicate that recommending isn't enough but that reminding and giving detailed information about the vaccine will increase vaccination rates independent of other factors.

11.
J Obstet Gynaecol Res ; 34(4): 578-84, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18937712

ABSTRACT

AIM: The aim of the present study was to investigate the levels of leptin, resistin and ghrelin in polycystic ovary syndrome (PCOS), and to assess their possible correlations with the hormonal and metabolic features of PCOS. METHODS: Sixteen obese (ObPCOS) and 12 lean (LeanPCOS) subjects with PCOS and 19 obese control subjects were enrolled in the study. RESULTS: Ghrelin, leptin and resistin concentrations were similar between groups when body mass index (BMI) was used as a covariate (P > 0.05). Mean androgen, SHBG, luteinizing hormone (LH) levels and luteinizing hormone/follicle-stimulating hormone (LH/FSH) ratio tended to be similar between polycystic ovary syndrome (PCOS) groups. However, when compared with the control group, SHBG was lower and androgen, LH levels and LH/FSH ratio were higher in the PCOS groups. Free testosterone levels significantly correlated with resistin (r = -0.38), SHBG correlated significantly with body mass index (BMI) (r = -0.45) and resistin (r = -0.67), LH/FSH ratio was significantly correlated with ghrelin (r = -0.52) and estradiol (E2) levels (r = 0.51). CONCLUSION: ObPCOS and LeanPCOS groups having higher LH/FSH ratios and lower SHBG levels suggest that there could be factors other than adiposity responsible for the clinical features of PCOS patients. In the light of our results, those factors can be suggested as ghrelin and E2 for the elevated LH/FSH ratio and resistin for the lowered SHBG.


Subject(s)
Ghrelin/blood , Leptin/blood , Polycystic Ovary Syndrome/blood , Resistin/blood , Adolescent , Female , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...